IMRX Archived Articles
Immuneering Navigating Towards Unlocking the Potential of Universal RAS/RAF Therapies
Published on November 30, 2024
Immuneering Corporation (NASDAQ:IMRX): Advancing Innovative Oncology Therapies Through Deep Cyclic Inhibition
Published on September 24, 2024